))
Episode 87 - Hemgenix, Rebyota, & Rezlidhia
Seri yang sudah diarsipkan ("Feed tidak aktif" status)
When?
This feed was archived on May 22, 2023 21:41 (
Why? Feed tidak aktif status. Server kami tidak mendapatkan feed podcast yang valid secara terus-menerus.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 348875567 series 3381350
Konten disediakan oleh Ian Parnigoni and Ian Parnigoni PharmD.. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh Ian Parnigoni and Ian Parnigoni PharmD. atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang dijelaskan di sini https://id.player.fm/legal.
Here are the links for everything discussed in Episode 87. Times are also below so feel free to skip around and get to the updates that interest you.
- (1:08) Approval of Hemgenix for Hemophilia B
- (4:45) Rebyota approved for recurrence of CDiff infection
- (9:39) New approval for AML with IDH1 mutation - Rezlidhia
CDC website for COVID information - get boosted!
FDA monkeypox response website
Connect with The Rx Daily Dose:
Twitter Instagram YouTube Linkedin Website
Email: therxdailydose@gmail.com
Connect with Ian Parnigoni PharmD. on social media:
Twitter Instagram Linkedin
87 episode
Bagikan
